Tag Archives: Approves

FDA Approves Livmarli (maralixibat) for the Treatment of Cholestatic Pruritus in Patients with Alagille Syndrome

[unable to retrieve full-text content]FOSTER CITY, Calif.–(BUSINESS WIRE)–Sep. 29, 2021– Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leader in rare liver disease, today announced that the U.S. Food and Drug Administration (FDA) has approved Livmarli (maralixibat) oral solution for… Drugs.com – New Drug Approvals

FDA Approves Opzelura (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD)

[unable to retrieve full-text content]WILMINGTON, Del.–(BUSINESS WIRE) September 21, 2021 — Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opzelura™ (ruxolitinib) cream for the short-term and non-continuous chronic treatment of… Drugs.com – New Drug Approvals

Covid-19 news: UK approves Pfizer and AstraZeneca booster shots

By Michael Le Page , Clare Wilson , Jessica Hamzelou , Sam Wong , Graham Lawton , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Vials of Pfizer/ BioNTech and Oxford/AstraZeneca Covid-19 vaccine. Dinendra Haria/SOPA Images/Shutterstock Latest coronavirus news as of 11am on 10 September Two covid-19 vaccines approved in UK for potential use as… Read More »

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)

FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC) BOSTON, July 20, 2021 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced U.S. Food & Drug Administration (FDA) approval of Bylvay (odevixibat), the first drug approved for the treatment of pruritus in… Read More »

FDA Approves Fexinidazole as the First All-Oral Treatment for Sleeping Sickness

July 19, 2021 — The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness (Human African trypanosomiasis) in patients 6 years of age and older and weighing at least 20 kg.Fexinidazole was developed as part of an innovative… Read More »